MicroPort Scientific (HKG:0853) said it expects Shanghai MicroPort Endovascular MedTech (Group) to report a year-over-year decrease in H1 profit and revenue, according to a Hong Kong bourse filing Monday.

Shares of the medical device company fell over 1% in afternoon trade Tuesday.

MicroPort Scientific owns 40% of EV Medtech and the business' results are consolidated with the financial statements of the company.

MicroPort Endovascular Medtech is expected to report 303.5 million yuan to 361.1 million yuan in profit for the first half of the year, down 11% to 25% year over year.

Revenue for the period is expected to be 708.5 million yuan to 787.2 million yuan, up to 10% lower when compared to a year prior.